SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 3, 2001, Pages 233-237

N-Methylformamide in advanced squamous cancer of the uterine cervix: An Eastern Cooperative Oncology Group phase II trial

(8) Rajdev, Lakshmi a Yu, Zi Fan b Wadler, Scott a Weller, Edie b Kahn, S Benham c Tormey, Douglass d Skeel, Roland e Wiernik, Peter H f

a ALBERT EINSTEIN CANCER CENTER (United States)

b DANA FARBER CANCER INSTITUTE (United States)

c DREXEL UNIVERSITY COLLEGE OF MEDICINE (United States)

d UNIVERSITY OF WISCONSIN (United States)

e MEDICAL COLLEGE OF OHIO (United States)

f NEW YORK MEDICAL COLLEGE (United States)

Author keywords

N Methylformamide; Squamous cell carcinoma; Uterine cervix

Indexed keywords

N METHYLFORMAMIDE;

ADENOSQUAMOUS CARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; LIVER TOXICITY; LUNG HEMORRHAGE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORMAMIDES; HUMANS; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0034844521 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1010672618269 Document Type: Article

Times cited : (5)

References (23)

1
- 0004098391
- New York: Oxford Press
- (1996) Cancer Epidemiology and Prevention. 2nd ed.
- Schottenfeld, H.¹ Fraumeni J.F., Jr.²

2
- 0031014450
- Cancer statistics. 1997
- (1997) Ca Cancer J Clin , vol.47 , pp. 5-27
- Parker, S.L.¹ Tong, T.² Bolden, S.³ Wingo, P.A.⁴

3
- 0002553793
- Cancer of the cervix, vagina, and vulva
- DeVita VT, Hellman S, Rosenberg SA (eds). Philadelphia, PA: Lippincott-Raven
- (1997) Cancer: Principles and Practice of Oncology, 5th ed. , pp. 1433-1478
- Eifel, P.J.¹ Berek, J.S.² Thigpen, J.T.³

4
- 0028354095
- A GOG phase II study of amonafide (NSC# 308847) in squamous cell carcinoma of the cervix
- (1994) Am J Clin Oncol , vol.17 , Issue.2 , pp. 125-128
- Asbury, R.F.¹ Blessing, T.A.² Soper, J.T.³

5
- 0027510162
- Treatment of advanced and recurrent squamous cell carcinoma of the uterine cervix with mitomycin-c, bleomycin and cisplatinum chemotherapy
- (1993) Gynecol Oncol , vol.48 , pp. 11-15
- Smith, H.O.¹ Stringer, C.A.² Kavanagh, J.J.³ Gershenson, D.M.⁴ Edwards, C.L.⁵ Wharton, J.T.⁶

6
- 0022551393
- Role of glutathizone depletion in the mechanism of action of N-Methylformamide and N′cimethylformaldamide in cultured human colon carcinoma cell lines
- (1986) Cancer Res , vol.46 , pp. 1297-1305
- Cordeiro, R.F.¹ Savarese, T.M.²

7
- 0003060912
- Retinoids and cancer in experimental animals
- Sporn MB, Roberts AM, Goodman DS, (eds). New York: Raven Press
- (1994) The Retinoids: Biology, Chemistry and Medicine, 2nd edn. , pp. 573-595
- Moon, R.C.¹ Mehta, R.G.² Rao, K.U.N.³

8
- 0003854710
- Effects of N-Methylformamide and related compounds in sarcoma 180
- (1953) Proc Soc Exp Bio Med , vol.84 , pp. 203-207
- Clarke, C.A.¹ Philips, F.S.² Sternberg, S.S.³

9
- 0003802061
- Antileukamische wirkung von N-Methylformamide
- (1954) Klin Wochenschrift , vol.32 , pp. 611-612
- Braunsteiner, H.¹

10
- 0003860201
- Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and NMF
- (1957) JNCI , vol.18 , pp. 413-441
- Potter, M.¹ Law, W.L.²

11
- 0021736880
- Differentiation modifiers
- (1984) Cancer , vol.54 , pp. 2766-2769
- Marks, P.A.¹ Rifkind, R.A.²

12
- 0028116705
- Inducing differentiation of transformed cells with hybrid polar compounds: A cell cycle dependent process
- (1994) Proc Natl Acad Sci , vol.91 , pp. 10251-10254
- Marks, P.¹ Richon, V.M.² Kiyokawa, H.³ Rifkind, R.A.⁴

13
- 1542588471
- Second generation hybrid polar compounds are potent inducers of transformed cell differentiation
- (1996) Proc Natl Acad Sci , vol.93 , pp. 5705-5708
- Richon, V.M.¹ Webb, Y.² Merger, R.³ Sheppard, T.⁴ Jursic, B.⁵ Ngo, L.⁶ Civoli, F.⁷ Breslow, R.⁸ Rifkind, R.A.⁹ Marks, P.¹⁰

14
- 0003506753
- Bethesda, MD, Division of Cancer Treatment, National Cancer Institute
- (1988) Guidelines for Reporting of Adverse Drug Reactions

15
- 0020396015
- Toxicity and response criteria of the Eastern Cooperative Oncology Group
- (1982) Am J Clin Oncol , vol.5 , pp. 649-655
- Oken, M.M.¹ Creech, R.H.² Tormey, D.C.³ Horton, J.⁴ Davis, T.E.⁵ McFadden, E.T.⁶ Carbone, P.P.⁷

16
- 0003798175
- National Cancer Institute, Bethesda, MD, NCI, June
- (1983) Phase I minutes: Division of Cancer Treatment

17
- 0003859697
- Phase I clinical and pharmacological trial of oral NMF
- abstr
- (1985) Proc AM Soc Clin Oncol , vol.4 , pp. 38
- Wienmann, M.C.¹ Cummings, F.J.²

18
- 0021881041
- Phase I study of NMF in patients with advanced cancer
- (1985) Cancer Treat Rep , vol.69 , pp. 489-493
- Ettinger, D.S.¹ Orr, D.W.² Rice, A.P.³

19
- 0021802333
- Phase I trial of NMF
- (1985) J Clin Oncol , vol.3 , pp. 853-857
- O'Dwyer, P.J.¹ Donehower, M.² Sigman, L.M.³

20
- 0021364284
- Phase I trial of NMF
- (1984) Cancer Treat Rep , vol.68 , pp. 607-610
- McVie, J.G.¹ Ten Bokkel Huinink, W.W.² Simonetti, G.³

21
- 0003860205
- NMF in metastatic colorectal cancer: A phase II study
- October 22-24, (abstr 2.12)
- (1986) Fifth NCI-EORTC Symposium on New Drugs in Cancer Therapy
- Verweij, J.¹ Klijn, J.G.M.² Planting, A.S.Th.³

22
- 0028343678
- Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: A randomized trial
- (1994) J Natl Cancer Inst , vol.86 , pp. 539
- Meyskens Fl., Jr.¹ Surwit, E.² Moon, T.E.³

23
- 0032408337
- 13-cis-retinoic acid or all-trans-retinoic acid plus interferon alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial
- (1998) Gyn Onc , vol.71 , pp. 386-390
- Weiss, G.R.¹ Liu, P.Y.² Lippman, S.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.